Nonspecific medication side effects and the nocebo phenomenon.

Patients taking active medications frequently experience adverse, nonspecific side effects that are not a direct result of the specific pharmacological action of the drug. Although this phenomenon is common, distressing, and costly, it is rarely studied and poorly understood. The nocebo phenomenon, in which placebos produce adverse side effects, offers some insight into nonspecific side effect reporting. We performed a focused review of the literature, which identified several factors that appear to be associated with the nocebo phenomenon and/or reporting of nonspecific side effects while taking active medication: the patient's expectations of adverse effects at the outset of treatment; a process of conditioning in which the patient learns from prior experiences to associate medication-taking with somatic symptoms; certain psychological characteristics such as anxiety, depression, and the tendency to somatize; and situational and contextual factors. Physicians and other health care personnel can attempt to ameliorate nonspecific side effects to active medications by identifying in advance those patients most at risk for developing them and by using a collaborative relationship with the patient to explain and help the patient to understand and tolerate these bothersome but nonharmful symptoms.

[1]  C. Larousse,et al.  Methodology and results of a survey of adverse reactions to a drug in private practice , 1977, European Journal of Clinical Pharmacology.

[2]  Y. Maugars,et al.  Interindividual variations in beliefs about the placebo effect: a study in 300 rheumatology inpatients and 100 nurses. , 2001, Joint, bone, spine : revue du rhumatisme.

[3]  G. Tollefson,et al.  No gender differences in placebo responses of patients with major depressive disorder , 2001, Biological Psychiatry.

[4]  A. Ströhle Increased response to a putative panicogenic nocebo administration in female patients with panic disorder. , 2000, Journal of psychiatric research.

[5]  D. Reda,et al.  Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study. , 2000, Archives of internal medicine.

[6]  L. Balant,et al.  Cultural differences: implications on drug therapy and global drug development. , 2000, International journal of clinical pharmacology and therapeutics.

[7]  Kay Brune,et al.  Incidence and Costs of Adverse Drug Reactions During Hospitalisation , 2000, Drug safety.

[8]  Rawlins,et al.  Attitudinal survey of voluntary reporting of adverse drug reactions. , 1999, British journal of clinical pharmacology.

[9]  M. Liang,et al.  Somatic style and symptom reporting in rheumatoid arthritis. , 1999, Psychosomatics.

[10]  A. Barsky,et al.  Functional Somatic Syndromes , 1999, Annals of Internal Medicine.

[11]  Anne Harrington,et al.  The Placebo Effect: An Interdisciplinary Exploration , 1999 .

[12]  M. Flaten,et al.  Drug-related information generates placebo and nocebo responses that modify the drug response. , 1999, Psychosomatic medicine.

[13]  N. Moore,et al.  Frequency and cost of serious adverse drug reactions in a department of general medicine. , 1998, British journal of clinical pharmacology.

[14]  E. Uhlenhuth,et al.  Medication side effects in anxious patients: negative placebo responses? , 1998, Journal of affective disorders.

[15]  R. Hahn,et al.  The nocebo phenomenon: concept, evidence, and implications for public health. , 1997, Preventive medicine.

[16]  K. Waterloo,et al.  Pharmacological classical conditioning in humans , 1997 .

[17]  Fabrizio Benedetti,et al.  Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide , 1997, Pain.

[18]  J. Kleijnen,et al.  Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness , 1996, BMJ.

[19]  S. von Ammon Cavanaugh,et al.  Placebo effects. Issues for clinical practice in psychiatry and medicine. , 1996, Psychosomatics.

[20]  J. A. Johnson,et al.  Drug-Related Morbidity and Mortality: A Cost-of-Illness Model , 1995 .

[21]  S. Kennedy,et al.  The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: a study of healthy male and female volunteers. , 1995, Journal of clinical psychopharmacology.

[22]  M. Drici,et al.  Influence of the behaviour pattern on the nocebo response of healthy volunteers. , 1995, British journal of clinical pharmacology.

[23]  D. Mj,et al.  Adverse reactions to drugs in a health center , 1994 .

[24]  W. Helsel,et al.  Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. , 1994, Annals of epidemiology.

[25]  R A Deyo,et al.  The importance of placebo effects in pain treatment and research. , 1994, JAMA.

[26]  S. Dworkin,et al.  Somatization and pain dispersion in chronic temporomandibular disorder pain , 1994, Pain.

[27]  P. Leaverton,et al.  Scientific and ethical issues in the use of placebo controls in clinical trials. , 1994, Annual review of public health.

[28]  L. Passman,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[29]  E. Nelson,et al.  The treatment of mild hypertension study. , 1993, JAMA.

[30]  E H Wagner,et al.  Patterns of antidepressant use in community practice. , 1993, General hospital psychiatry.

[31]  P. Rosenzweig,et al.  The placebo effect in healthy volunteers: Influence of experimental conditions on the adverse events profile during phase I studies , 1993, Clinical pharmacology and therapeutics.

[32]  J. Ferguson Alprazolam-XR: Patient Acceptability, Safety, and Tolerability , 1993, Psychiatric Annals.

[33]  M. Shepherd,et al.  The placebo: from specificity to the non-specific and back , 1993, Psychological Medicine.

[34]  T R Einarson,et al.  Drug-Related Hospital Admissions , 1993, The Annals of pharmacotherapy.

[35]  P. Lees-Haley,et al.  Biases in Perception and Reporting following a Perceived Toxic Exposure , 1992, Perceptual and motor skills.

[36]  V. K. Bajaj,et al.  Background noise in healthy volunteers--a consideration in adverse drug reaction studies. , 1992, Indian journal of physiology and pharmacology.

[37]  O. Sortland,et al.  Iopentol in Urography , 1992 .

[38]  O. Sortland,et al.  Iopentol in urography. A clinical comparison between iopentol and metrizoate including delayed reactions. , 1992, Acta radiologica.

[39]  Wayne Katon,et al.  Adequacy and Duration of Antidepressant Treatment in Primary Care , 1992, Medical care.

[40]  M. Stockton,et al.  Allergy to penicillin: fable or fact? , 1991, BMJ.

[41]  N. Cutler,et al.  Idioventricular Rhythm: Hypervagotonia Associated with Placebo , 1991, DICP : the annals of pharmacotherapy.

[42]  G. Fein,et al.  A double-blind study of symptom provocation to determine food sensitivity. , 1990, The New England journal of medicine.

[43]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.

[44]  D. Long,et al.  Placebo responses to medical device therapy for pain. , 1989, Stereotactic and functional neurosurgery.

[45]  J. Holland,et al.  Prevalence, predictors, and course of anticipatory nausea in women receiving adjuvant chemotherapy for breast cancer , 1988, Cancer.

[46]  G. Hedlin,et al.  Penicillin allergy--a rare paediatric condition? , 1988, Archives of disease in childhood.

[47]  A health study of two communities near the Stringfellow Waste Disposal site. , 1988, Archives of environmental health.

[48]  C. A. Hart,et al.  Gas gangrene: a cautionary tale , 1988, British medical journal.

[49]  P. Dobkin,et al.  Anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment: Prevalence, etiology, and behavioral interventions☆ , 1988 .

[50]  J Singer,et al.  The consent form as a possible cause of side effects , 1987, Clinical pharmacology and therapeutics.

[51]  M. Weir,et al.  Attitudes to adverse drug reactions and their reporting among medical practitioners. , 1987, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[52]  M. Andrykowski,et al.  Longitudinal analysis of the development of anticipatory nausea. , 1987, Journal of consulting and clinical psychology.

[53]  H. Sørensen,et al.  Is type I penicillin allergy overdiagnosed in children? , 1986, Scandinavian journal of primary health care.

[54]  L. J. Reed,et al.  Community exposure to hazardous waste disposal sites: assessing reporting bias. , 1985, American journal of epidemiology.

[55]  A. Barsky Nonpharmacologic aspects of medication. , 1983, Archives of internal medicine.

[56]  N. Oswald Penicillin allergy: a suspect label. , 1983, British medical journal.

[57]  L. W. Buckalew,et al.  An Investigation of Drug Expectancy as a Function of Capsule Color and Size and Preparation Form , 1982, Journal of clinical psychopharmacology.

[58]  James W. Pennebaker,et al.  The psychology of physical symptoms , 1982 .

[59]  A. Schweiger,et al.  Nocebo: The psychologic induction of pain , 1981, The Pavlovian journal of biological science.

[60]  S. Siegel Morphine analgesic tolerance: its situation specificity supports a Pavlovian conditioning model. , 1976, Science.

[61]  C. Buncher,et al.  Demonstration to medical students of placebo responses and non-drug factors. , 1972, Lancet.

[62]  T. Luparello,et al.  The Interaction of Psychologic Stimuli and Pharmacologic Agents on Airway Reactivity in Asthmatic Subjects , 1970, Psychosomatic medicine.

[63]  S. Garattini,et al.  Monosodium Glutamate and the Chinese Restaurant Syndrome , 1970, Nature.

[64]  D. Mcnair,et al.  Drug-personality interaction in intensive outpatient treatment. , 1970, Archives of general psychiatry.

[65]  J. Cleobury Adverse Non-drug Reactions , 1969 .

[66]  E. R. Mcfadden,et al.  The Mechanism of Action of Suggestion in the Induction of Acute Asthma Attacks , 1969, Psychosomatic medicine.

[67]  E. R. Mcfadden,et al.  Influences of Suggestion on Airway Reactivity in Asthmatic Subjects , 1968, Psychosomatic medicine.

[68]  D. Lowenthal,et al.  Adverse nondrug reactions. , 1968, The New England journal of medicine.

[69]  P. Kissel,et al.  Placebos et Effet Placebo en Medecine , 1965 .

[70]  Pogge Rc The toxic placebo. II. The case of the partial patient. , 1963 .

[71]  R. Pogge The toxic placebo. II. The case of the partial patient. , 1963, Medical times.

[72]  Kennedy Wp The nocebo reaction. , 1961 .

[73]  E. Kast,et al.  Influence of the doctor-patient relationship on drug action. , 1961, The Illinois medical journal.

[74]  W. Kennedy The nocebo reaction. , 1961, Medical world.

[75]  C. Joyce Consistent differences in individual reactions to drugs and dummies. , 1959, British journal of pharmacology and chemotherapy.

[76]  J. Groen,et al.  Reproducible psychogenic attacks of asthma; a laboratory study. , 1956, Journal of psychosomatic research.

[77]  S. Wolf,et al.  Effects of placebo administration and occurrence of toxic reactions. , 1954, Journal of the American Medical Association.